Viral Vitalism

Consumer Intelligence

Consumer Health Claims

Frameworks for evaluating wellness, supplement, device, and medical-adjacent claims.

3 published articlesBuilding this topic
MedicineEarly evidenceGLP-1

GLP-1s, Dopamine, and Addiction: The Substance Use Signal

GLP-1 medications may do more than reduce appetite for food. Early clinical trials, real-world data, and preclinical research suggest they may also affect craving, reward, alcohol intake, and substance-use patterns - but the science is still developing.

16 min readRead->

Related research

Useful source library entries

Related topics

SupplementsCompounded GLP-1s

Vital Signals

Get the weekly health signal without the wellness fog.

A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.

No spam. No miracle claims. Just better health signal.

By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.